News Choose Year All Years 2026 (1) 2025 (6) 2024 (6) 2023 (2) 2022 (2) 2021 (1) Search Press Releases Found 18 Results May 13, 2026 Rectify Pharmaceuticals to Present Preclinical Data on New Dual Targeted ABCB4/BSEP Positive Functional Modulator at EASL 2026 Read More December 22, 2025 Rectify and Boehringer Ingelheim Collaborate to Advance First-in-class Treatments for Chronic Kidney Disease Read More June 6, 2025 Rectify Pharma Presents Translational Data Demonstrating Improvements in Kidney Function and Reductions in Vascular Calcification at ERA 2025 Read More May 21, 2025 Rectify Pharma to Present Translational Data on Novel Approach to Treat Chronic Kidney Disease and Vascular Calcification at ERA 2025 Read More May 9, 2025 Rectify Pharma Presents Translational Data for Novel Positive Functional Modulator Demonstrating Improved Biliary and Liver Health at EASL 2025 Read More April 23, 2025 Rectify Pharma to Share Preclinical Data Highlighting Progress in Hepatobiliary Program at EASL 2025 Read More April 7, 2025 Rectify Pharma Announces Publication of BSEP Transporter Biophysical Characterization in Communications Biology Read More November 18, 2024 Rectify Pharma Presents Preclinical Data Supporting Development of Lead Candidate RTY-694 at The Liver Meeting® 2024 Read More 123»
Read More